Morbidity and mortality associated with vasopressin analogue treatment

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue 3, 2006, Pages 197-201

  Toumba, Meropi ^a   Stanhope, Richard ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; DESMOPRESSIN; INDOMETACIN; LAMOTRIGINE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN INHIBITOR; SODIUM; VASOPRESSIN; VASOPRESSIN DERIVATIVE;

ABDOMINAL PAIN; ACUTE DISEASE; ALLERGIC REACTION; ARTICLE; ATTENTION DEFICIT DISORDER; AWARENESS; BEHAVIOR DISORDER; BLEEDING DISORDER; BODY WEIGHT; BRAIN EDEMA; CARDIOVASCULAR DISEASE; CENTRAL PONTINE MYELINOLYSIS; CHILD; CHILD HEALTH CARE; CLINICAL TRIAL; CYSTIC FIBROSIS; DEHYDRATION; DEVELOPMENTAL DISORDER; DIABETES INSIPIDUS; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG WITHDRAWAL; ENURESIS; EPISTAXIS; FAMILY HEALTH; FEVER; FLUID INTAKE; HALLUCINATION; HEADACHE; HEALTH EDUCATION; HIGH RISK PATIENT; HOME MONITORING; HUMAN; HYDRATION; HYPERKINESIA; HYPERNATREMIA; HYPERTENSION; HYPONATREMIA; KIDNEY DISEASE; MORBIDITY; MORTALITY; NAUSEA; NEUROLOGIC DISEASE; NOCTURNAL ENURESIS; NOSE CONGESTION; PHYSICIAN; RHINITIS; SIDE EFFECT; SODIUM BLOOD LEVEL; VOMITING; WATER INTOXICATION; WATER RETENTION;

EID: 33645537369     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2006.19.3.197     Document Type: Article

References (39)

1. Westgren U, Wittstrom C, Harris AS. Oral desmopressin in central diabetes insipidus. Arch Dis Child 1986; 61: 247-250.
2. Moffat ME, Harlos S, Kirshen AJ, Burd L. Desmopressin acetate and nocturnal enuresis: How much do we know? Pediatrics 1993; 92: 420-425.
3. Hjalmas K, Bengtsson B. Efficacy, safety, and dosing of desmopressin for nocturnal enuresis in Europe. Clin Pediatr (Phila) 1993; Spec No: 19-24.
4. Wolfish N, Barkin J, Gorodzinsky F, Schwarz R. The Canadian enuresis study and evaluation. Short- and long-term safety and efficacy of an oral desmopressin preparation. Scand J Urol Nephrol 2003; 37: 22-27.
5. Muller D, Roehr CC, Eggert P. Comparative tolerability of drug treatment for nocturnal enuresis in children. Drug Safty 2004; 27: 717-27.
6. Harris AS. Clinical experience with desmopressin: Efficacy and safety in central diabetes insipidus and in other conditions. J Pediatr 1989; 114: 711-718.
7. Salzman EW, Weinstein MJ, Weintraub RM, Ware JA, Thurer RL, Robertson L, Donovan A, Gaffney T, Bertele V, Troll J. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. N Engl J Med 1986; 314: 1402-1406.
8. Koskimies O, Pylkkanen J, Vilska J. Water intoxication in infants caused by the urine concentration test with vasopressin analogue (DDAVP). Acta Paediatr Scand 1984; 73: 131-132.
9. Vilhardt H. Basic pharmacology of vasopressin. A review. Drug Invest 1990; 2 (Suppl 5): 2-8.
10. Zaoral M, Kolc J, Sorm F. Aminoacids and peptides LXXI. Synthesis of 1-desmopressin-8-D-amino-butyrine vasopressin, 1-desamino-8-D-lysine vasopressin and 1-desamino-8-D-arginine vasopressin. Collect Czech Chem Commun 1967; 32: 1250-1257.
11. Williams TDM, Dunger DB, Lyon CC, Lewis RJ, Taylor F, Lightman SL. Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children. J Clin Endocrinol Metab 1986; 63: 129-132.
12. Rizzo V, Albanese A, Stanhope R. Morbidity and mortality associated with vasopressin replacement therapy in children. J Pediatr Endocrinol Metab 2001; 14: 861-867.
13. British National Formulary, British Medical Association, Royal Pharmaceutical Society of Great Britain, March 2005; Section: 6.5.2, p 380 and 7.4.3, p 415.
14. Von Gontard A, Lehmkuhl G. Desmopressin side effects. J Am Acad Child Adolesc Psychiatry 1996; 35: 129-130.
15. Schwab M, Wenzel D, Ruder H. Hyponatraemia and cerebral convulsion due to short term control of enuresis nocturna. Eur J Pediatr 1996; 155: 46-48.
16. Dunn AL, Powers JR, Ribeiro MJ, Rickles FR, Abshire TC. Adverse events during use of intranasal desmopressin acetate for haemophilia A and von Willebrand disease: A case report and review of 40 patients. Haemophilia 2000; 6: 11-14.
17. Hartman S, Reinhart W. Fatal complications of desmopressin. Lancet 1995; 345: 1302-1303.
18. Neveus T, Lackgren G, Tuvemo T, Stenberg A. Osmoregulation and desmopressin pharmacokinetics in enuretic children. Pediatr 1999; 103: 65-70.
19. Neuhuse TJ, von der Heiden-Ranz M. Hyponatraemia and cerebral convulsion after a single dose of intranasal DDAVP. Pediatr Nephrol 1997; 11: 527.
20. Wieting JM, Dykstra DD, Ruggiero MP, Robbins GB, Galusha K. Central nervous system ischemia after Varicella infection and desmopressin therapy for enuresis. J Am Osteopaht Assoc 1997; 97: 293-295.
21. Fjellestad-Paulson A, Laborde K, Czernichow P. Water balance hormones during long-term follow-up of oral DDAVP treatment in diabetes insipidus. Acta Paediatr 1993; 82: 752-757.
22. Baylis P, Cheetham T. Diabetes insipidus. Arch Dis Child 1998; 79: 84-89.
23. Lyen KR, Grant DB. Endocrine function, morbidity and mortality after surgery for craniopharygioma. Arch Dis Child 1982; 57: 837-841.
24. Newman CB, Levine LS, New MI. Endocrine function in children with intrasellar and suprasellar neoplasms; before and after therapy. Am J Dis Child 1981; 135: 259-262.
25. Thomsett MJ, Conte FA, Kaplan SL, Grumbach MM. Endocrine and neurological outcome in childhood craniopharyngioma: Review of effect in treatment in 42 patients. J Pediatr 1980; 97: 728-735.
26. Lindsay RS, Seckl JR, Padfield PL. The triple phase response-problems of water balance after pituitary surgery. Postgrad Med J 1995; 71: 439-441.
27. Balestrieri FJ, Chernow B, Rainey TG. Postcraniotomy diabetes insipidus, who's at risk? Crit Care Med 1982; 10: 108-110.
28. Matarazzo P, Genitori L, Lala R, Andreo M, Grossetti R, de Sanctis C. Endocrine function and water metabolism in children and adolescents with surgically treated intra/parasellar tumors. J Pediatr Enocrinol Metab 2004; 17: 1487-1495.
29. Wise-Faberowski L, Soriano S, Ferrari L, McManus M, Wolfsdorf J, Majzoup J, Scott M, Truog R, Rockoff M. Perioperative management of diabetes insipidus in children. J Neurosurg Anesthesiol 2004; 16: 220-225.
30. Mewasingh L, Aylett S, Kirkham F, Stanhope R. Hyponatraemia associated with lamotrigine in cranial diabetes insipidus. Lancet 2000; 356: 656.
31. Tormey WP, O'Laoire SA. Severe prolonged antidiuresis following desmopressin and carbamazepine interaction in postoperative diabetes insipidus. Eur J Int Med 1992; 3: 341-343.
32. Van Amelsvoort T, Bakshi R, Devaux CB, Schwabe S. Hyponatraemia associated with carbamazebine and oxcarbamazepine therapy: A review. Epilepsia 1994; 35: 181-88.
33. Agnoli GC, Borgatti R, Cacciari M, Lenzi P, Marinelli M, Stipo L. Low-dose desmopressin infusion: Renal action in healthy women in moderate salt retention and depletion, and interactions with prostanoids. Prostaglandins Leukt Essent Fatty Acids 2002; 67: 263-273.
34. Adrogue H, Madias N. Hyponatraemia. N Engl J Med 2000; 342: 1581-1589.
35. Sterns RH, Cappuccio JD, Silver SM, Cohen EP. Neurological sequelae after treatment of severe hyponatraemia: A multicenter prospective. J Am Soc Nephrol 1994; 4: 1522-1530.
36. Brown WD. Osmotic demyelination disorders: Central and extrapontine myelinolysis. Curr Opin Neurol 2000; 13: 691-697.
37. Ashrafian H, Davey P. A review of the causes of central ponitne myelinolysis: Yet another apoptotic illness? Eur J Neurol 2001; 8: 103-109.
38. Laureno R, Karp BI. Myelinolysis after correction of hyponatraemia. Ann Int Med 1997; 126: 57-62.
39. Lebl J, Kolska M, Zavacka A, Eliasek J, Gut J, Biolek J. Cerebral edema in enuretic children during low dose desmopressin treatment: A preventable complication. Eur J Pediatr 2001; 160: 159-162.